News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
09 27 2016 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will host an Investor Day for institutional investors and financial analysts in New York City on...
09 21 2016 Company also introduces molecular Zika testing for serum and paired urineQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of a new antibody test service that aids the diagnosis of infection...
09 16 2016 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, was named for the twelfth consecutive year in the North America Dow Jones Sustainability Index...
09 15 2016 Annual Drug Testing Index Reveals Fifth Straight Year of Increases in Detection Rate of Amphetamine and Heroin; Marijuana Positivity Increases 47 Percent Since 2013 in Oral Fluid TestingFollowing years of declines, the percentage of employees in the combined U.S. workforce testing positive for drugs has steadily increased over the last three years to a 10-year high, according to...
09 13 2016 - Revenue services collaboration with Optum360 to reduce billing complexity and deliver new technology solutions to provide more transparency into costs, ultimately enhancing the patient experience for lab and related servicesWAKEFIELD, Mass. & MADISON, N.J.--(BUSINESS WIRE)--Optum, a leading information and technology-enabled health services business, and Quest Diagnostics (NYSE:DGX), the world's leading provider of...
